In September 2024, Hikma Pharmaceuticals PLC finalized the acquisition of Xellia Pharmaceuticals US finished dosage form business with a deal including a facility in Ohio, Sales and marketing capabilities, and an R&D center in Croatia, aiming to strengthen the commercial portfolio and production supplements
Tirazepatide (TZT), a dual glucagon-like peptide-1 (GLP-1)and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist may be effective in managing Covid-19-induced hyperglycemia in diabetic and non-diabetic patients
Reports can be made via email at [email protected], through the FDA website, or by calling the Center for Drug Regulation and Research at (02) 8809-5596
According to Yale Medicine, these drugs are primarily used for type 2 diabetes management and obesity treatment, and they work best alongside healthy eating and physical activity
99% Purity
The company said Friday it signed a strategic partnership with Korean biotech Tionlab Therapeutics to develop and commercialize the long-acting GLP-1 treatment globally